A Landmark Diet Trial Ran for Five Months Inside a Research Protocol. Vynleads Asks the Harder Question: What Keeps an Eating Pattern Going in Month Six?

Vynleads (OTCQB: VYND) shared a behavior-change perspective on a randomized clinical trial published in Cell Metabolism (August 27, 2026; DOI 10.1016/j.cmet.2026.07.020), conducted at Washington University School of Medicine. The trial compared ketogenic, Mediterranean, and low-fat diets over five months: all three groups lost roughly 10% of body weight, the ketogenic group saw a 67% reduction in liver fat versus 45% for the other two diets, and roughly half of participants with prediabetes no longer met the study's prediabetes criteria by its measures.

What the Trial Found

Two details deserve as much attention as the headline number: all three groups — not just one — recorded roughly 10% weight loss over the study period, and that window was five months inside a research protocol, with the structure, accountability, and support a trial provides. The published findings do not address what happens after that structure ends. Vynleads takes no position on which diet anyone should follow or on the comparative merits of the diets studied — those conversations belong with a qualified clinician or registered dietitian nutritionist.

The Question That Starts in Month Six

“When we read a trial like this, our attention goes to the support structure behind the results: participants had a research team, a defined protocol, and built-in accountability for five months,” said Alex Mannine, Co-Founder and CEO of Vynleads. “Our work starts where that structure ends — taking whatever eating pattern a person and their care team have chosen and helping it survive month six, when the study team is gone and life is busy again.” The company's free learning library covers the surrounding territory: how to prevent prediabetes from becoming diabetes, why prediabetes usually has no symptoms, the science connecting liver fat, MASH, and metabolic health, and what makes a diet work for type 2 diabetes.

Built for Month Six

The Done With Diabetes™ program is designed for the window this trial leaves open: an 8-week Success Blueprint builds the routine, the Dr. Smith AI Wellness Coach provides educational lifestyle support with human review and safety checks (never medical advice), and Lifetime Wellness Mode supports the years after. It is diet-agnostic by design. Learn more about Vynleads.

Vynleads is not affiliated with Washington University School of Medicine, Cell Metabolism, or the study's authors. Descriptions of trial results preserve the study's own terminology; long-term durability was not addressed in the coverage reviewed. This commentary is not diet science or nutrition advice.